Molecure S.A. (WSE:MOC)
7.04
-0.18 (-2.49%)
Sep 25, 2026, 12:58 PM CET
Molecure Market Cap
Molecure has a market cap or net worth of 148.75 million as of September 24, 2026. Its market cap has decreased by -1.43% in one year.
Market Cap
148.75M
Enterprise Value
131.88M
Revenue
6.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.04
ChartMarket Cap Chart
Since April 19, 2018, Molecure's market cap has decreased from 338.43M to 148.75M, a decrease of -56.05%. That is a compound annual growth rate of -9.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 148.75M | 9.39% |
| Dec 30, 2025 | 135.98M | -20.03% |
| Dec 30, 2024 | 170.04M | -48.21% |
| Dec 29, 2023 | 328.30M | 64.10% |
| Dec 30, 2022 | 200.07M | -61.66% |
| Dec 30, 2021 | 521.79M | -24.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 593.58M |
| Captor Therapeutics Spolka Akcyjna | 446.64M |
| Bioceltix | 420.45M |
| Ryvu Therapeutics | 366.22M |
| BIOTON | 304.82M |
| Synthaverse | 215.19M |
| Mabion | 126.71M |
| Poltreg | 118.92M |